The study covers geographic analysis that includes regions like South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa) and important players/vendors such as Thermo Fisher Scientific Inc. (United States), Charles River Laboratories International, Inc. (United States), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics etc The report will help user gain market insights, future trends and growth prospects for forecast period of 2019-2025.
Request a sample report @ https://www.htfmarketreport.com/sample-report/2298685-global-mycoplasma-testing-market-2
Global Mycoplasma Testing Market Overview:
The increasing incidence of mycoplasma contamination, as well as increasing research and development activities, will help to boost global Mycoplasma Testing market in the forecasted period. Mycoplasma testing is mainly used to help determine if Mycoplasma pneumonia is the cause of a respiratory tract infection. Also, It used to help diagnose a systemic infection that is thought to be due to mycoplasma. In the biotechnology sector, they are growing used for drug screening and development, and large-scale manufacturing of biological compounds. Some of the key players profiled in the study are Thermo Fisher Scientific Inc. (United States), Charles River Laboratories International, Inc. (United States), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), SGS S.A. (Switzerland), American Type Culture Collection (United States), Bionique Testing Laboratories, Inc. (United States), InvivoGen (United States) and PromoCell GmbH (Germany).
According to Market Analyst at HTF, the Global Mycoplasma Testing market may see a growth rate of 12.5% and would reach the market size of USD1.19 Billion by 2024.
On the basis of geography, the market of Mycoplasma Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. ELISA (Enzyme-linked Immunosorbent Assay) will boost the Mycoplasma Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Academic Research Institutions and Organizations will boost the Mycoplasma Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
Government Support for Pharma as well as Biotech Industry
Technological Advancement in Mycoplasma Testing
Market Trend
High Demand Due to Cell Culture Contamination
Huge R&D Investments in Life Sciences
Restraints
Stringent Government Regulations
Growing Concern Regarding High Degree of Consolidation Acts for New Entrants
Opportunities
Huge Potential for Pharmaceuticals Outsourcing
Challenges
Dearth Of Skilled Workforce
Major Market Developments:
On 14th March 2019, Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing. The expansion of the portfolio with the new Lucetta™ 2 Luminometer establishes Lonza as the leading provider of fast, simple and accurate mycoplasma detection solutions,
On 10th July 2018, ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, has announced the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures.
Target Audience:
Mycoplasma Testing Instrument Manufacturers, Mycoplasma Testing Instrument Vendors, Distributors, and Service Providers, Pharmaceutical and Biotechnology Companies, Academic Research Institutes Related to Mycoplasma Testing and Contract Research Organizations
Major Objectives Focused through this Study
• To define, describe, and forecast the Global Mycoplasma Testing market on the basis of product [Instruments, Kits & Reagents [Elimination Kits & Reagent, Standards & Controls, PCR Assay, Stains, Nucleic Acid Detection, Other] and Services] , application [Cell Line Testing, Virus Testing, End of Production Cells Testing and Others], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Mycoplasma Testing market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Mycoplasma Testing industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Place a Purchase Order For Market Study (Single User License) at: https://www.htfmarketreport.com/buy-now?format=1&report=2298685
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are WuXi AppTec (United States), Norgen Biotek Corp. (Canada), Agilent Technologies (United States), Biotools, B & M Labs, S.A (Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories (United States), GeneCopoeia, Inc. (United States), GenBio (Canada), Hylabs (Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc. (United States), Sartorius AG (Germany), Savyon Diagnostics (Israel) and ScienCell Research Laboratories, Inc. (Canada).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Mycoplasma Testing market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/2298685-global-mycoplasma-testing-market-2
Strategic Points Covered in Table of Content of Global Mycoplasma Testing Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Global Mycoplasma Testing Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025market. (Introduction, Scope of the Report)Chapter 2: Exclusive Summary – the basic information of the Global Mycoplasma Testing Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 Market. (Introduction)
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Global Mycoplasma Testing Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 (Market Dynamics- Drivers, Trends, Opportunity, Restraints & Challenges)
Chapter 4: Presenting the Global Mycoplasma Testing Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region 2013-2018
Chapter 6: Evaluating the leading manufacturers of the Global Mycoplasma Testing Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source.
….Continued
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2298685-global-mycoplasma-testing-market-2
Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Media Contact
Company Name: HTF Market Intelligence Consulting Private Limited
Contact Person: Craig Francis
Email: Send Email
Phone: 2063171218
Address:Unit No. 429, Parsonage Road
City: Edison
State: New Jersey
Country: United States
Website: www.htfmarketreport.com/reports/2298685-global-mycoplasma-testing-market-2